﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>01</Month>
        <DAY>19</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Investigate the co-culture effects of BM-mesenchymal stem cells on the promotion of apoptotic pathways of CD34+leukemic stem cells</ArticleTitle>
    <FirstPage>31302</FirstPage>
    <LastPage>31302</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.31302</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mei</FirstName>
        <LastName>Ding</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5820-301X</Identifier>
      </Author>
      <Author>
        <FirstName>Chuanhua</FirstName>
        <LastName>Jia</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0003-6861-6186</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.31302</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>04</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: The potential clinical application of mesenchymal stem cells (MSCs) in cell-based treatment makes them particularly interesting. The use of MSC-engaged therapies in cancer treatment is becoming more and more promising. Although the specifics of their activity have not yet been conclusively established, a variety of growth factors released by these cells are known to provide such multifunctional qualities. Methods: Through the measurement of cytokine levels, Annexin-V, and possible signaling pathways linked to apoptosis, we have assessed the impact of MSCs on CD34+leukemic stem cells (LSCs) enriched from the KG1-a cell line. Additionally, culture medium was taken from the experimental and control groups for the IL-2 and IL-4 measurement following a 7-day co-culture.  Results: Co-culture conditions were observed to promote early and late apoptosis, although this increase just was statistically significant in late apoptosis. The co-cultured conditioned media clearly showed a large amount of IL-2, but there was an insignificant rise in IL-4. Also, MSCs significantly increased the protein expression of P16, P21, and p-P38 and significantly decreased C-Myc, and TERC.  Conclusion: It can be concluded that the mentioned effects of IL-2 cytokine released from MSCs on CD34+LSCs maybe were applied by the components of P16, P21, and p-P38, C-Myc signaling pathways.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Apoptosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">CD34+LSCs</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cell free therapy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Extracellular cytokines</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mesenchymal stem cells</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>